alexa Nanomedicine in Thrombosis | Open Access Journals
ISSN: 2157-7439
Journal of Nanomedicine & Nanotechnology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Nanomedicine in Thrombosis

Antonio Peramo*

Department of Oral and Maxillofacial Surgery, University of Michigan, Ann Arbor, Michigan 48109, USA

*Corresponding Author:
Antonio Peramo
Department of Oral and Maxillofacial Surgery
University of Michigan, Ann Arbor
Michigan 48109, USA
E-mail: [email protected]

Received Date: April 06, 2012; Accepted Date: April 12, 2012; Published Date: April 16, 2012

Citation: Peramo A (2012) Nanomedicine in Thrombosis. J Nanomedic Nanotechnol 3:e106. doi:10.4172/2157-7439.1000e106

Copyright: © 2012 Peramo A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nanomedicine & Nanotechnology

There is an increased number of research articles – in the Journal of Nanomedicine and Nanotechnology and elsewhere – describing possible applications of nanomedicine in cardiovascular diseases. These diseases have an increased incidence in developed countries due to an aging population and will also gradually increase in developing countries. In general, the nanomedical applications described in the literature have been focusing on imaging and therapy of atherosclerosis [1] and in vivo and ex-vivo identification and marking of vascular biosignatures [2], to name just two examples.

Thrombosis is, however, an area of cardiovascular research that would substantially benefit of novel and sustained nanotechnology approaches. This area is not being investigated and opportunities abound for nanotechnologists and biomedical researchers to collaborate to advance nanomedical solutions for improving diagnosis and understanding progression and recurrence of thrombosis [3] During thrombosis there is a formation of blood clots with the vessels that lead to arterial or vein obstruction, inflammation, as well as the production of pro-coagulant vesicles known as microparticles, released primarily from platelets.

Given that the field is so widely open we will mention a few interesting applications, but the list is obviously much larger. While the toxicological effects of synthetic nanoparticles that are starting to be used in nanomedicine, like quantum dots or carbon nanotubes, have been under study for some time, the involvement of these or other nanoparticles in thrombosis and their effects are mostly unknown. A few recent studies have shown that surface carboxylated quantum dots may cause vascular thrombosis in the pulmonary circulation [4] or that carbon nanotubes accelerate thrombus formation in the circulation [5] and activate platelets [6]. Additional studies should be necessary, particularly in patient populations at risk of thrombotic diseases.

In nanomedicine it is common to use the procedures to deliver cargo (drugs, DNA or other molecules) to selected cell types and tissues [7]. These techniques should also be explored and implemented in circulating and in the endothelial cells known to have an active participation in thrombosis. Methods for the intracellular delivery of markers to cells and vesicles involved in thrombosis may provide critical information for their identification and tracking, and will make possible to perform studies that requires leaving intact (unmodified) the outer membrane of the cells. Implementation of these methods will certainly be easier in animal model of thrombosis [8] where nanoparticles can be used in in vivo localization, tracking of cells in thrombus formation and selective targeting/identification of cells as well as in ex vivo identification of markers for prediction of thrombotic events.

Unlike regular drug delivery and molecular therapeutic models, nanomedicine allows the development of a variety of nanoagents that can perform multiple tasks in the early identification and resolution of disease. In essence, we expect this emerging field of nanomedicine in thrombosis to meet the demand for innovative approaches in the diagnosis and treatment of the complications associated with this disease.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11555
  • [From(publication date):
    May-2012 - Sep 22, 2017]
  • Breakdown by view type
  • HTML page views : 7785
  • PDF downloads :3770
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords